3 Big Pharma Stocks with Huge Future Growth Potential

3 Big Pharma Stocks with Huge Future Growth Potential

You might not be aware of it, but big pharma stocks have gone through a difficult period for many years. A lot of the big drugs at the big pharma stocks went off patent, and the revenue for some of the big pharma stocks has fallen off as a result. Some of the big pharma […]

Trichotillomania / Hair Pulling Disorder

Trichotillomania / Hair Pulling Disorder

Trichotillomania (TTM), commonly known as “hair pulling disorder”, is an impulse control disorder in which hair loss occurs because the patient cannot resist the urge to pull out their own hair, despite trying to stop. The most common areas affected include the scalp, eyebrows, and eyelids. This results in noticeable hair loss, clearly visible as […]

Tanner Pharma Group Signs a Distribution Agreement for Partner Therapeutics' Product, Leukine®

Tanner Pharma Group Signs a Distribution Agreement for Partner Therapeutics' Product, Leukine®

CHARLOTTE, N.C.–(BUSINESS WIRE)–May 24, 2018–Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc. (PTx), an integrated biopharmaceutical company. The agreement names Tanner Pharma Group as a distributor of Leukine® (sargramostim) in areas outside of the United States and Canada where the […]

FDA declines to approve Recro Pharma's non-opioid pain shot

FDA declines to approve Recro Pharma's non-opioid pain shot

The U.S. Food and Drug Administration on Thursday declined to approve Recro Pharma’s IV meloxicam noting the pain-relieving effect of the drug did not meet its expectations. A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo The drug is a non-opioid injection to […]

Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M

Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M

Xconomy Raleigh-Durham —  Growing up in China, Zhi Hong saw the healthcare challenges of his homeland firsthand. Despite the country’s economic strides, life science innovation there lags advances made in the West, he says. The GlaxoSmithKline veteran now wants to use his experience to adjust the balance. Backed by $260 million in financing, his startup, […]

Clinigen signs agreement with Nordic Pharma for aprotinin

Clinigen signs agreement with Nordic Pharma for aprotinin

BURTON-ON-TRENT, England–(BUSINESS WIRE)–May 24, 2018–Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has signed an agreement with Nordic Pharma Ltd. (‘Nordic Pharma’) to manage the supply and distribution of aprotinin in a range of countries in Asia Pacific and South Africa. Aprotinin Injection belongs to a group of medicines called anti-fibrinolytics […]

Your Daily Pharma Scoop: Cellectis Trial Protocol, Tesaro Takeover Rumor, Kitov Down Before PDUFA

Your Daily Pharma Scoop: Cellectis Trial Protocol, Tesaro Takeover Rumor, Kitov Down Before PDUFA

Analysis focus: CLLS Cellectis (NASDAQ:CLLS) is a smallcap company, well-funded with $300+mn in quick cash, $1.2bn market cap, that is second wave of CAR-T developers. The key difference that Cellectis brings to the CAR-T space is that unlike current autologous CAR-T therapies, its product is allogenic, meaning it is cheaper, faster, more efficient, medicine of […]

Sebi fines AstraZeneca Pharma, 3 ex-officials Rs 4 lakh

Sebi fines AstraZeneca Pharma, 3 ex-officials Rs 4 lakh

Markets regulator imposed a total penalty of Rs 4 lakh on AstraZeneca Pharma India and its three former senior officials for not complying with insider trading norms. The officials are Lars Walan, Supriya Kumar Guha and Pawan Singhal. Walan was the managing director of AstraZeneca Pharma India from March 29, 2001 to April 1, 2004 […]

BRIEF-Cara Therapeutics And Vifor Fresenius Medical Care Renal Pharma Enter Into Ex-US Licensing Agreement

BRIEF-Cara Therapeutics And Vifor Fresenius Medical Care Renal Pharma Enter Into Ex-US Licensing Agreement

May 23 (Reuters) – Cara Therapeutics Inc: * CARA THERAPEUTICS AND VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA (VFMCRP) ENTER INTO EX-U.S. LICENSING AGREEMENT TO COMMERCIALIZE KORSUVA™ INJECTION IN DIALYSIS PATIENTS WITH PRURITUS * CARA THERAPEUTICS INC – CARA ELIGIBLE FOR UP TO $470 MILLION IN REGULATORY AND COMMERCIAL MILESTONES * CARA THERAPEUTICS INC – VFMCRP […]

1 2 3 66